Clonal comparison of acinetobacter strains isolated from intensive care patients and the intensive care unit environment

Turkish Journal of Medical Sciences

Volumn 44, Issue 4, 2014, Pages 643-648

  Kirkgöz, Esra ^a   Zer, Yasemin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Nosocomial infection; Rep PCR; Source

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; BACTERIAL DNA;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CLONAL SPECIES; CORRELATION COEFFICIENT; DNA EXTRACTION; DNA FINGERPRINTING; FEMALE; GENETIC SIMILARITY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; VERY ELDERLY; ACINETOBACTER INFECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CROSS INFECTION; ISOLATION AND PURIFICATION; MEDICAL DEVICE CONTAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NUCLEOTIDE REPEAT; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; YOUNG ADULT;

EID: 84901016924     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1304-126     Document Type: Article

References (20)

1. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36: 1938-1941.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-951.
3. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
4. Aygün G, Demirkiran O, Utku T, Mete B, Ürkmez S, Yilmaz M, Yaşar H, Dikmen Y, Oztürk R. Environmental contamination during carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 2002; 52: 259-262.
5. Joseph AE, Massire C, Hall TA, Ranken R, Pennella DT, Ivy CA, Blyn LB, Hofstadler SA, Endy T P, Scott PT et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 2006; 44: 2921-2932.
6. Villegas M V, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003; 24: 284-295.
7. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130-137.
8. Sesli Çetin E, Kaya S, Tetik T, Cicioǧlu Aridoǧan B. Klinik örneklerden izole edilen Acinetobacter baumannii suşlari{dotless}ni{dotless}n örneklere göre daǧi{dotless}li{dotless}mi{dotless} ve antibiyotik duyarli{dotless}li{dotless}klari{dotless}. Ankem Derg 2006; 20: 202-205 (in Turkish).
9. Corbella X, Montero A, Pujol M, Dominquez MA, Ayats J, Argerich MJ, Garrigosa F, Ariza J, Gudiol F. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38: 4089-4095.
10. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am J Infect Control 2002; 30: 386-390.
11. Seifert H, Dolzani L, Bressan R, Reijden T, Strijen B, Stefanik D, Heersma H, Dijkshoorn L. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
12. Simor AE, Lee M, Vearncombe M, Jones-Paul L, Barry C, Gomez M, Fish JS, Cartotto RC, Palmer R, Louie M. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002; 23: 261-267.
13. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002; 8: 689-693.
14. Ayan M, Durmaz R, Aktas E, Durmaz B. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J Hosp Infect 2003; 54: 39-45.
15. Wendt C, Dietze B, Dietz E, Rüden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 1997; 35: 1394-1397.
16. Karsligil T, Balci I, Zer Y. Antibacterial sensitivity of Acinetobacter strains isolated from nosocomial infections. J Int Med Res 2004; 32: 436-441.
17. Özgür Akin FE, Bayram A, Balci I. Çoǧul dirençli Acinetobacter baumannii izolatlari{dotless}nda kolistin, polimiksin B ve tigesiklin direncinin saptanmasi{dotless}nda disk difüzyon, E test ve buyyon mikrodilüsyon yöntemlerinin karşi{dotless}laşti{dotless}ri{dotless}lmasi{dotless}. Microbiyol Bul 2010; 44: 203-210 (in Turkish).
18. Poque JM, Mann T, Barber KE, Kaye KS. Carbapenem-resistant Acinetobacter baumannii epidemiology, surveillance and management. Expert Rev Anti Infect Ter 2013; 11: 383-393.
19. Zarrillii R, Crispino M, Bagattini M, Barretta E, Popolo AD, Triassi M, Villari P. Molecular epidemiology of sequential outbreak of Acinetobacter baumannii in an intensive care units shows the emergence of carbapenem resistance. J Clin Microbiol 2004; 42: 946-953.
20. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836.